Abstract
Abstract Introduction Carriers of the A allele of a single nucleotide polymorphism of the TNFα gene (G308A, rs1800629) are relatively resilient to vigilant attention performance impairment from total sleep deprivation (TSD), as compared to G/G homozygotes, and even exhibit a small performance advantage at baseline. The mechanism underlying this effect remains unclear. As TNFα is a sleep regulatory substance, we investigated whether TNFα G308A genotype is associated with systematic differences in markers of sleep homeostasis. Methods N=168 healthy young adults (ages 27.4±5.4y; 86 women) participated in one of seven in-laboratory TSD studies. During TSD, performance was assessed every 2–3h using a psychomotor vigilance test (PVT). The TSD period was preceded and followed by nocturnal sleep opportunities (baseline and recovery, respectively), which were recorded polysomnographically and scored according to AASM criteria. The EEG (C3-M2 derivation) of stages N2 and N3 non-REM sleep was investigated using spectral analysis. Results The genotype distribution of the sample was 0.6% A/A, 26.8% A/G, 72.6% G/G, in Hardy-Weinberg equilibrium (P=0.14). As documented previously, A allele carriers, compared to G/G homozygotes, had fewer PVT lapses (RTs>500ms) at baseline and during TSD, indicating greater resilience to sleep deprivation. During both baseline and recovery sleep, A allele carriers, compared to G/G homozygotes, displayed reduced power in the delta (0.8–4.0Hz; P=0.017) and theta (4.2–8.0Hz; P=0.004) bands of the non-REM sleep EEG. Conclusion The performance advantage of the A allele carriers brings to mind the “banking sleep” phenomenon previously observed in sleep deprivation studies with prior sleep extension, suggesting that the A allele carriers gained this advantage by essentially being able to bank sleep. If this interpretation is correct, then the diminished power in the delta and theta bands of the non-REM sleep EEG in the A allele carriers, which suggests reduced homeostatic sleep pressure during both baseline and recovery sleep, may imply that the A allele carriers operate at a lower homeostatic setpoint due to an underlying advantage in the recuperative efficiency of sleep. Support (If Any) NIH R01HL070154, R21CA167691, R01HL105768; ONR N00014-13-C-0063, N00014-13-1-0302, FAA DTFAAC-11-A-00003, CDMRP W81XWH-16-1-0319, USAMRDC W81XWH-05-1-0099, and an SRS Elliot D. Weitzman, M.D. Research Grant.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.